Examkin

Soru

Zorluk: OrtaOrdering Laboratory Tests

A 4545-year-old man comes to the clinic for a follow-up visit for hypertension. He was diagnosed with hypertension 22 years ago. Despite adherence to a regimen of amlodipine, lisinopril, and hydrochlorothiazide at maximal tolerated doses, his blood pressure remains consistently elevated. He reports occasional episodes of muscle weakness and cramps over the past 33 months but otherwise feels well. He does not have headaches, palpitations, or sweating. Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 168/98 mm Hg168/98 \text{ mm Hg}, and pulse 78/min78/\text{min}. Physical examination shows no abdominal bruits, normal peripheral pulses, and no peripheral edema.

Laboratory results from today are as follows:
Sodium: 144 mEq/L144 \text{ mEq/L}
Potassium: 2.9 mEq/L2.9 \text{ mEq/L}
Chloride: 104 mEq/L104 \text{ mEq/L}
Bicarbonate: 29 mEq/L29 \text{ mEq/L}
Blood urea nitrogen: 14 mg/dL14 \text{ mg/dL}
Creatinine: 0.9 mg/dL0.9 \text{ mg/dL}

Which of the following is the most appropriate next step in evaluation?

  1. Plasma aldosterone concentration and plasma renin activityCevap
  2. B
    Intravenous saline infusion test
  3. C
    Renal artery Doppler ultrasonography
  4. D
    24-hour urine fractionated metanephrines
  5. E
    Adrenal venous sampling

Cevap

Plasma aldosterone concentration and plasma renin activity
The correct answer is the measurement of plasma aldosterone concentration and plasma renin activity. This patient presents with resistant hypertension (blood pressure >140/90 mm Hg>140/90 \text{ mm Hg} despite using ≥3\ge 3 antihypertensive agents of different classes, including a diuretic) and significant hypokalemia (<3.5 mEq/L<3.5 \text{ mEq/L}). This clinical picture is highly suspicious for primary hyperaldosteronism. The most appropriate initial screening step is to measure the plasma aldosterone concentration (PAC) and plasma renin activity (PRA). In primary hyperaldosteronism, autonomous aldosterone secretion suppresses renin, resulting in an elevated PAC, suppressed PRA, and a high PAC/PRA ratio (typically >20>20).

Adım Adım Çözüm

1
Identify the patient's core clinical problem.
The patient has resistant hypertension (uncontrolled on three antihypertensive medications including a diuretic) accompanied by symptomatic hypokalemia and metabolic alkalosis.
Recognizing the combination of resistant hypertension and spontaneous or diuretic-induced hypokalemia strongly points toward a specific secondary cause of hypertension.
2
Formulate a differential diagnosis for secondary hypertension with hypokalemia.
The most likely diagnosis is primary hyperaldosteronism (Conn syndrome). Other causes like renal artery stenosis or pheochromocytoma are less likely due to the absence of bruits and typical adrenergic symptoms.
Primary hyperaldosteronism is characterized by excessive aldosterone secretion, leading to distal renal tubular sodium retention (causing hypertension) and potassium/hydrogen excretion (causing hypokalemia and metabolic alkalosis).
3
Determine the most appropriate initial diagnostic laboratory test.
The recommended initial screening test is the simultaneous measurement of plasma aldosterone concentration (PAC) and plasma renin activity (PRA) to calculate the PAC/PRA ratio.
A high PAC and a suppressed PRA (resulting in an elevated ratio) indicate autonomous aldosterone production, making it the most sensitive and specific initial screening tool.

Anahtar Kavram

The initial laboratory evaluation for suspected primary hyperaldosteronism in patients with resistant hypertension and hypokalemia is the plasma aldosterone concentration to plasma renin activity ratio.
Bu soruyu puanla

Konular

Ordering Laboratory Tests

Bu konudan daha fazla soru